Het is mogelijk om onze medisch gewichtsverlies arts te zien om Ozepmic, Mounjaro of Wegovy persoonlijk te bespreken in Alkmaar, Amsterdam, Hilversum, Eindhoven, Rotterdam, Utrecht of Zwolle
This blog, based on IQVIAs 18th March 2026 webinar on the future of the Obesity Medicines market, looks ahead to the next phase of that transformation, examining how the obesity market evolves from 2026 to 2030, and how the drivers of success shift from rapid adoption to differentiation, longterm performance and systemlevel impact
Anyone treating these peptides as a get lean fast and then stop tool is going to be disappointed
Such differences in compliance between GLP-1RA preparations are mainly due to the differences between injection devices [172]
Muscle injection causes faster, more variable absorption and increased injection site pain
For example, a report of a dermal hypersensitivity reaction to dulaglutide presenting as coalescing pink macules and papules in a morbilliform pattern has been reported
